These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11569964)

  • 1. Questions about HIV causing AIDS? Viral load and T-cell (CD4) counts: why they really matter.
    AIDS Treat News; 2001 May; (364):7-8. PubMed ID: 11569964
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement in CD4+ cell counts despite persistently detectable HIV load.
    Levitz SM
    N Engl J Med; 1998 Apr; 338(15):1074-5. PubMed ID: 9537882
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
    Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for early antiretroviral therapy in patients with CD4 cell counts > 500 cells/mm3.
    Soriano V; Gómez-Cano M; Mas A; Villalba N; Bravo R; González-Lahoz J
    Antivir Ther; 1996 Dec; 1(4):264-5. PubMed ID: 11324829
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.
    Olsen CH; Gatell J; Ledergerber B; Katlama C; Friis-Møller N; Weber J; Horban A; Staszewski S; Lundgren JD; Phillips AN;
    AIDS; 2005 Feb; 19(3):319-30. PubMed ID: 15718843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS therapy. Failure isn't what it used to be...but neither is success.
    Cohen J
    Science; 1998 Feb; 279(5354):1133-4. PubMed ID: 9508685
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-assessing the virological approach to HIV pathogenesis: can it explain AIDS as an immunological disease?
    Whitaker RE
    J Theor Biol; 1997 Jul; 187(1):45-56. PubMed ID: 9236107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.
    Hazuda DJ; Young SD; Guare JP; Anthony NJ; Gomez RP; Wai JS; Vacca JP; Handt L; Motzel SL; Klein HJ; Dornadula G; Danovich RM; Witmer MV; Wilson KA; Tussey L; Schleif WA; Gabryelski LS; Jin L; Miller MD; Casimiro DR; Emini EA; Shiver JW
    Science; 2004 Jul; 305(5683):528-32. PubMed ID: 15247437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.
    Naugler WE; Yong FH; Carey VJ; Dragavon JA; Coombs RW; Frenkel LM
    J Infect Dis; 2002 Feb; 185(4):448-55. PubMed ID: 11865396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of phenotyping and replication capacity in anti-HIV therapeutics.
    Baliga CS; Sutton RE
    Curr Opin Mol Ther; 2004 Jun; 6(3):308-17. PubMed ID: 15264434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
    Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simpler tests for immune cells could transform AIDS care in Africa.
    Willyard C
    Nat Med; 2007 Oct; 13(10):1131. PubMed ID: 17917650
    [No Abstract]   [Full Text] [Related]  

  • 16. Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group.
    Spritzler J; Mildvan D; Russo A; Asthana D; Livnat D; Schock B; Kagan J; Landay A; Haas DW;
    Clin Infect Dis; 2003 Aug; 37(4):551-8. PubMed ID: 12905140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral rounds. Virologic failure: true or false?
    Gallant JE; Shafer R
    AIDS Clin Care; 2005 Sep; 17(9):84-5. PubMed ID: 16201048
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV replication.
    Kingman S
    Mol Med Today; 1995 Apr; 1(1):2. PubMed ID: 9415128
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV-1 intermittent drug intensification in HIV-1-infected patients naive for antiretrovirals.
    Rusconi S; Argenteri B; Galli M; d'Arminio-Monforte A; Moroni M
    Antivir Ther; 1999; 4(3):183-4. PubMed ID: 12731759
    [No Abstract]   [Full Text] [Related]  

  • 20. False-negative HIV viral load in AIDS patients.
    Simons P; Muyldermans G; Lacor P; Zissis G; Lauwers S
    AIDS; 1997 Nov; 11(14):1783-4. PubMed ID: 9386817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.